ArticleFrontiers in oncology2026

Mechanistic drivers of PD-L1/CTLA-4 checkpoint inhibitor-associated immune toxicity and systemic organ injury.

Junfeng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.